Endocrine, Metabolic & Immune Disorders -Drug Targets
Vasiliki Sideri
1
, George Antonakos
2
, Andreas Fretzayas
1
, Achilleas Attilakos
1
, Charalambos
Chrelias
3
, Vasiliki Papaevangelou
1
, Polyxeni Nicolaidou
1
and Anna Papadopoulou
1,*
1
3
rd
Department of Paediatrics, National and Kapodistrian University of Athens, “Attikon” University General Hospital,
Athens, Greece;
2
Laboratory of Clinical Biochemistry, “Attikon” University General Hospital, Athens, Greece;
3
3
rd
Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, “Attikon” University
General Hospital, Athens, Greece
A R T I C L E H I S T O R Y
Received: March 13, 2018
Revised: May 31, 2018
Accepted: June 27, 2018
DOI:
10.2174/1871530318666180723103117
Abstract: Background/Objectives: The aim of this work was to evaluate the current vitamin D status
in healthy pregnant women and their newborns living in Greece and assess possible associations be-
tween 25(OH)D and anthropometric features of their fetuses and newborns.
Materials & Methods: 81 healthy women were monitored during pregnancy. Biochemical markers
related to bone metabolism, 25(OH)D and PTH levels were measured in serum samples of mother-
newborn pairs at 1st trimester of pregnancy and at delivery in mothers, in cord blood and at the 3
rd
day
of life of newborns.
Results: Maternal 25(OH)D levels at the 1st trimester of pregnancy (22.6±9.2ng/ml) were significantly
higher than those at delivery (19.2±9.2ng/ml) (p<0.001). Furthermore, umbilical 25(OH)D levels
(21.3±9.3ng/ml) were higher than maternal at delivery (p=0.005) and neonatal levels (19.4±10.4
ng/ml) (p=0.021). Only 57.3% of the mothers at the first trimester and 46.7% at delivery as well as
55.8% of the fetuses and 38.5% of the neonates had adequate vitamin D levels (25(OH)D≥30ng/ml). A
significant positive correlation was found between fetal femur length at the 22nd week of gestation and
maternal 25(ΟΗ)D at the 1st trimester of pregnancy (r=0.36, p=0.048) while body length was signifi-
cantly higher in newborns whose mothers had sufficient 25(OH)D levels (51.5±2.1cm) compared with
those whose mothers had insufficient or deficient 25(OH)D levels at delivery (50.6±2.0cm) (p=0.047).
Conclusion: The study confirms inadequate levels of vitamin D in pregnant women in Greece associ-
ated with inadequate vitamin D levels of their fetuses and newborns.
Keywords: Vitamin D deficiency/insufficiency, pregnancy, fetus, newborn, PTH levels, hypovitaminosis.
1. INTRODUCTION
The implication of vitamin D in multiple biological cir-
cuits such as immunomodulation, cellular proliferation and
differentiation led to extensive research regarding the deter-
mination of the optimal serum levels and the clinical conse-
quences of low or high blood concentrations [1, 2]. Serum
vitamin D levels are mainly expressed by 25(OH)D which
constitutes the human reservoir of vitamin D due to its long
half-time life (2-3weeks) [1, 3] and subsequently determines
the deficient, insufficient or sufficient vitamin D status.
Given that vitamin D is found naturally only in a few foods,
such as egg yolk, salmon, and liver, maternal 25(OH)D lev-
els depend basically on the amount of sunlight exposure and
*Address correspondence to this author at the Biochemist-Molecular Biolo-
gist, 3
rd
Department of Pediatrics, National and Kapodistrian University of
Athens, “Attikon” University General Hospital, 1, Rimini Str, 12462 Ath-
ens, Greece; Tel: +302105832228; Fax: +302105832229; E-mail: anpa-
pado@med.uoa.gr
on vitamin D supplementation [1]. Furthermore, the amount
of UV exposure available for the cutaneous synthesis of vi-
tamin D depends on several parameters such as the time
spent outdoors, skin pigmentation, body mass index, clothing
habits, the latitude of a region, the use of sunscreens, the
season of the year and air pollution [1].
Hypovitaminosis D has been reported by a significant
number of epidemiological and observational studies in vari-
ous physiological and pathological conditions in human life,
in different geographic regions and different cultures [2, 4].
However, it should be noticed that besides the emerging
data, an inconclusive debate is still in progress regarding
vitamin D normal ranges. Based on clinical observations on
bone health and laboratory measurements of bone markers,
research groups and organizations publish guidelines for
25(OH)D ranges and vitamin D supplementation. In particu-
lar, the Endocrine Society, defines as deficient, insufficient
and sufficient vitamin D status 25(OH)D serum levels less
than 20ng/ml (<50nmol/L); 21-29 ng/ml (52,5-75nmol/L)
2212-3873/19 $58.00+.00 © 2019 Bentham Science Publishers
Send Orders for Reprints to reprints@benthamscience.ae
Endocrine, Metabolic & Immune Disorders - Drug Targets, 2019, 19, 159-165
159
RESEARCH ARTICLE
Hypovitaminosis D in Healthy Pregnant Women and their Newborns in
Greece